SMARCC1 and breast cancer: Another research group found that methylated BAF155 shares genome binding sites with BRD4 and H3K27ac, and methylated BAF155 increased tumor metastasis by attracting BRD4 and activating SE-dependent oncogenes in breast cancer [111].